FDA Authorizes COVID Drug Pemgarda for High-Risk Patients

FDA Authorizes COVID Drug Pemgarda for High-Risk Patients A Yale Medicine expert explains the significance of a new preventive medication to protect certain immunocompromised people against COVID-19. Yale Medicine

The Food and Drug Administration (FDA) granted an emergency use authorization (EUA) to a medicine meant to protect certain immunocompromised people against COVID-19.

The medicine, pemivibart (brand name Pemgarda™), is for people who are at least 12 years of age, weigh more than 88 pounds, and are moderately to severely immunocompromised.

...